Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Choline and Potassium are closely matched across evidence, studies, and safety.
Verdict
Mixed evidence
5 of 11 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
6 of 10 studies with measurable effects showed benefit.
Top outcomes
250-500mg daily (varies by form)
Morning or with meals, Alpha-GPC before cognitive tasks
Alpha-GPC or CDP-Choline (Citicoline)
99-500mg daily from supplements (food provides more)
With food to reduce GI upset, Spread throughout day, During/after exercise for athletes
Potassium Citrate or Potassium Gluconate
2-4 weeks
4-8 weeks
1-2 weeks
With high doses
2-4 weeks
1-2 weeks
Long-term
With excess or kidney issues
Association of choline and betaine with the risk of cardiovascular disease and all-cause mortality: Meta-analysis
European journal of clinical investigation (2023) · Meta analysis · n=33009
Random-effects model results showed that highest versus lowest quantile of circulating choline concentrations were associated with the risk of CVD (RR = 1.29, 95% CI: 1.04-1.61) and all-cause mortality (RR = 1.62, 95% CI: 1.12-2.36).
Higher dietary choline intake is associated with increased risk of all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of cohort studies
Nutrition research (New York, N.Y.) (2024) · Meta analysis · n=482778
This study showed that each 100 mg/day increment in choline consumption was significantly associated with a 6% and 11% higher risk of all-cause and cardiovascular disease mortality respectively.
Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
Journal of Alzheimer's disease : JAD (2023) · Meta analysis · n=1326
We found significant effects of α-GPC in combination with donepezil on cognition [4 RCTs, mean difference (MD):1.72, 95% confidence interval (CI): 0.20 to 3.25], functional outcomes [3 RCTs, MD:0.79, 95% CI: 0.34 to 1.23], and behavioral outcomes [4 RCTs; MD: -7.61, 95% CI: -10.31 to -4.91].
Effect of changes in potassium intake on blood pressure: a dose–response meta-analysis of randomized clinical trials (2000–2024)
Clinical Kidney Journal (2024) · Meta analysis · n=2500
Dose-response analysis of RCTs from 2000-2024
Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Nutrients (2024) · Meta analysis
Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations.
Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies
BMC medicine (2024) · Meta analysis · n=237036
Meta-analysis examining Potassium efficacy
Based on meta-analysis of α-GPC with donepezil showing cognitive benefits and citicoline studies. Effects vary significantly by choline form - α-GPC and CDP-choline show higher bioavailability. Most evidence is in older adults or those with existing cognitive impairment.
AI-estimated from published studies. Interpret as directional guidance.
Both Choline and Potassium are closely matched — the best choice depends on your specific health goals.
Both Choline and Potassium score equally (85) for reduce inflammation.
No known interactions between Choline and Potassium have been documented in our database. However, always consult a healthcare provider before combining supplements.